Cas 61013-20-5,10,11-dimethoxy-6-methyl-6H-dibenzo[de,g]quinoline

61013-20-5

Post Buying Request

Basic information

Product Name: 10,11-dimethoxy-6-methyl-6H-dibenzo[de,g]quinoline
Synonyms:
CAS NO:61013-20-5
Molecular Formula:
Molecular Weight: 291.349
EINECS: N/A
Product Categories: N/A

Chemical Properties

Melting Point: N/A
Boiling Point: N/A
Flash Point: N/A
Appearance: N/A
Density: N/A
Refractive Index: N/A
Storage Temp.: N/A
Solubility: N/A
CAS DataBase Reference: 10,11-dimethoxy-6-methyl-6H-dibenzo[de,g]quinoline(CAS DataBase Reference)
NIST Chemistry Reference: 10,11-dimethoxy-6-methyl-6H-dibenzo[de,g]quinoline(61013-20-5)
EPA Substance Registry System: 10,11-dimethoxy-6-methyl-6H-dibenzo[de,g]quinoline(61013-20-5)

Safety Data

Hazard Codes: N/A
Statements: N/A
Safety Statements: N/A
WGK Germany:
RTECS:
HazardClass: N/A
PackingGroup: N/A
Hazardous Substances Data: 61013-20-5(Hazardous Substances Data)

Suppliers
Usage
Upstream product
Downstream Products
Article

61013-20-5 Suppliers

Recommended suppliers

61013-20-5 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 61013-20-5 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 6,1,0,1 and 3 respectively; the second part has 2 digits, 2 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 61013-20:
(7*6)+(6*1)+(5*0)+(4*1)+(3*3)+(2*2)+(1*0)=65
65 % 10 = 5
So 61013-20-5 is a valid CAS Registry Number.

61013-20-5Upstream product

61013-20-5Downstream Products

61013-20-5Relevant academic research and scientific papers

PHARMACEUTICAL COMPOSITIONS OF (6AS)-6-METHYL-5,6,6A,7-TETRAHYDRO-4H-DIBENZO[DE,G]QUINOLINE-10,11-DIOL

-

, (2021/02/12)

This invention relates to pharmaceutical compositions for enhancing the solubility of (6aS)-6-methyl-5,6,6a,7-tetrahydro-4H-dibenzo[de,g]quinoline-10,11-diol and salt forms thereof.

PHARMACEUTICAL COMPOSITION FOR USE IN THE TREATMENT OF NEUROLOGICAL DISEASES

-

, (2021/02/12)

The present invention relates to pharmaceutical compositions for administration to mammals that include (6aS)-6-methyl-5,6,6a,7-tetrahydro-4H-dibenzo[de,g]quinoline-10,11-diol or a pharmaceutically acceptable salt thereof and at least one pharmaceutically acceptable excipient that provides pharmacokinetic profiles useful for the treatment of neurodegenerative diseases.

Post a RFQ

Cas No.:

Product Name:

Quantity:

Email:

Company name:

Valid Period:

Detailed Requirements:

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

What can I do for you?
Get Best Price

Get Best Price for 61013-20-5